Legius syndrome: case report and review of literature.

Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. JAMA (2009) 2.72

Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet (2007) 2.55

Neurofibromatosis type 1. J Am Acad Dermatol (2009) 2.41

An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23

A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1. Genes Dev (2012) 1.33

The diagnostic and clinical significance of café-au-lait macules. Pediatr Clin North Am (2010) 1.24

Review and update of SPRED1 mutations causing Legius syndrome. Hum Mutat (2012) 1.13

Legius syndrome, an Update. Molecular pathology of mutations in SPRED1. Keio J Med (2013) 1.10

p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas. Eur J Hum Genet (2014) 1.00

Observations on intelligence and behavior in 15 patients with Legius syndrome. Am J Med Genet C Semin Med Genet (2011) 0.89

Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1. JAMA Dermatol (2014) 0.82